1275.9.47002 Boehringer Ingelheim Investigational Site
Oslo
0 studies enrolling now · 1 studies all time
What they study most
Diabetes Mellitus, Type 2
Studies at this site
Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes
— Completed